Evidence map›Paper›PMID 26062471›Full record

ArticleInternational journal of oncology2015

Huachansu mediates cell death in non-Hodgkin's lymphoma by induction of caspase-3 and inhibition of MAP kinase.

Ekem T Efuet, Xiao-Ping Ding, Carrie Cartwright, Yong Pan, Lorenzo Cohen, Peiying Yang

Open access · bronzeAbstract read
In one paragraph

Article in International journal of oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ekem T EfuetDepartment of General Oncology, Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Xiao-Ping DingDepartment of General Oncology, Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Carrie CartwrightDepartment of General Oncology, Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Yong PanDepartment of General Oncology, Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Lorenzo CohenDepartment of General Oncology, Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Peiying YangDepartment of General Oncology, Integrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Huachansu (HCS), a hot water extract of the skin glands of Bufo gargarizans (B. melanostictus), has been used extensively in the treatment of various solid tumors in Asia, particularly in China. However, its effect on the growth of malignancies of hematopoietic origin, particularly lymphomas, is limited. Here we investigated the antiproliferative effect and molecular mechanisms of HCS using non-Hodgkin's lymphoma (NHL) Raji, Ramos, and Namalwa cells and the mantle cell lymphoma cells SP53. HCS inhibited proliferation in these cell lines with an IC50 ranging from 3.1 to 25 µl/ml. At a concentration of 25 µl/ml, HCS triggered a sub-G1 arrest in Ramos cells and induced early to late apoptotic cell death. Cleaved caspase-3 was formed in a concentration-dependent manner in Ramos cells following treatment with HCS for 24 h. Intriguingly, when the Ramos cells were treated with the caspase inhibitor ZDEVD, the apoptotic activity of HCS was partially blocked. Furthermore, HCS also blocked the expression of survivin and pRB proteins in a concentration-dependent manner in Ramos cells. Mechanistically, HCS downregulated both the MAPK gene and proteins in Ramos cells. Collectively, our data suggest that HCS is effective in inducing cell death and apoptosis, in part, by activating caspase-3 activity and suppressing MAP kinase in NHL cells.

Indexed as

Amphibian VenomsAntineoplastic Agents, PhytogenicApoptosisCaspase 3Cell Line, TumorCell ProliferationDose-Response Relationship, DrugDrugs, Chinese HerbalGene Expression Regulation, NeoplasticHumansInhibitor of Apoptosis ProteinsLymphoma, Non-HodgkinMitogen-Activated Protein KinasesProtein Kinase InhibitorsRetinoblastoma ProteinSurvivinAmphibian VenomsAntineoplastic Agents, PhytogenicBIRC5 protein, humanCaspase 3Drugs, Chinese HerbalhuachansuInhibitor of Apoptosis ProteinsMitogen-Activated Protein KinasesProtein Kinase InhibitorsRetinoblastoma ProteinSurvivin

Identifiers

PMID26062471
PMCPMC6904102
OpenAlexW1766263436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.